Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Debt / NOTE 2.500% 6/0
-
Number of holders
-
46
-
Total 13F principal, excl. options
-
635M
-
Principal change
-
-11M
-
Total reported value, excl. options
-
$588M
-
Value change
-
-$13.2M
-
Number of buys
-
23
-
Number of sells
-
-21
-
Price
-
$0.92
Significant Holders of HAEMONETICS CORP MASS - NOTE 2.500% 6/0 as of Q3 2025
55 filings reported holding 405024AD2 - HAEMONETICS CORP MASS - NOTE 2.500% 6/0 as of Q3 2025.
HAEMONETICS CORP MASS - NOTE 2.500% 6/0 has 46 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $635M of principal
.
Largest 10 bondholders include Linden Advisors LP ($163M of principal), CAMDEN ASSET MANAGEMENT L P /CA ($69.3M of principal), Invesco Ltd. ($59.2M of principal), WOLVERINE ASSET MANAGEMENT LLC ($56.3M of principal), FRANKLIN RESOURCES INC ($37.4M of principal), ZAZOVE ASSOCIATES LLC ($32M of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($29.4M of principal), Wellesley Asset Management ($28.4M of principal), Calamos Advisors LLC ($22.5M of principal), and WELLS FARGO & COMPANY/MN ($21.2M of principal).
This table shows the top 46 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.